Compounds > irinotecan
Page last updated: 2024-08-24

irinotecan and streptomycin

irinotecan has been researched along with streptomycin in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Hagiwara, T; Hirohashi, M; Kamataki, T; Kato, M; Nagai, E; Nomura, M; Takasuna, K; Yokoi, T1
Hagiwara, T; Kamataki, T; Kumazawa, E; Nagai, E; Onose, S; Takasuna, K; Watanabe, K; Yoshida, S1
Asakawa, N; Kado, S; Kaneda, N; Kato, I; Kurita, A; Matsumoto, T; Onoue, M; Uchida, K; Yokokura, T1

Reviews

1 review(s) available for irinotecan and streptomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

5 other study(ies) available for irinotecan and streptomycin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Inhibition of intestinal microflora beta-glucuronidase modifies the distribution of the active metabolite of the antitumor agent, irinotecan hydrochloride (CPT-11) in rats.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:4

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Area Under Curve; Bacteria; Camptothecin; Diarrhea; Enzyme Inhibitors; Glucuronidase; Injections, Intravenous; Intestine, Large; Intestine, Small; Irinotecan; Male; Penicillins; Rats; Rats, Wistar; Streptomycin

1998
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea.
    Cancer chemotherapy and pharmacology, 2006, Volume: 58, Issue:4

    Topics: Animals; Antidiarrheals; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Enzyme Inhibitors; Flavonoids; Glucuronidase; Intestines; Irinotecan; Male; Medicine, Kampo; Penicillins; Rats; Rats, Wistar; Streptomycin

2006
Streptomycin alleviates irinotecan-induced delayed-onset diarrhea in rats by a mechanism other than inhibition of β-glucuronidase activity in intestinal lumen.
    Cancer chemotherapy and pharmacology, 2011, Volume: 67, Issue:1

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Glucuronidase; Glucuronosyltransferase; Intestinal Mucosa; Irinotecan; Male; Penicillin G; Rats; Rats, Gunn; Rats, Wistar; Streptomycin; Time Factors

2011